Advertisement
Screener

MEDRESPONSE CORP. Form 8-K: Current report

MEDRESPONSE CORP. Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2016-02-26: Form 8-K; Period of report 2016-02-25; Description 4.01 Changes in Registrant's Certifying Accountant.
  • 2016-01-19: Form 8-K; Period of report 2015-12-03; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 8.01.
  • 2015-11-12: Form 8-K; Period of report 2015-11-10; Description 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.01.
  • 2015-09-29: Form 8-K; Period of report 2015-09-29; Description 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.01.
FiledFormPeriod of reportDescriptionDetailsDocument
2016-02-268-K2016-02-254.01 Changes in Registrant's Certifying Accountantmedr_8k.htm
2016-01-198-K2015-12-035.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events8.01 On or about December 9, 2015, FINRA approved the name change referenced in Item 5.03 herein and a ticker symbol change from “MTCP” to “MEDR,” which were announced by FINRA on or about December 10, 2015.form8-k.htm
2015-11-128-K2015-11-105.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.01 On November 10, 2015, Dr. Art Malone sold 5,000,000 shares of common stock of Merecot Corp. (the “Company”) to Andrew Stepansky for $25,000 of Mr. Stepansky’s personal funds, constituting a change of control of the Company as Mr. Stepansky now owns 52.3% of the voting securities of the Company after transfer of the shares.
5.02 Also on November 10, 2015, Dr. Art Malone resigned as President, Treasurer, Secretary and Director of the Company, and appointed Andrew Stepansky as President, Treasurer, Secretary and Director of the Company.
form8-k.htm
2015-09-298-K2015-09-295.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.01 On September 17th 2015 Dr. Malone became the controlling interest in Merecot Corp. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Effective September 17, 2015, on act by consent of shareholders, Dr. Arthur Malone is nominated to be Director, President, Secretary, and Treasurer.form8-k.htm
2015-05-088-K2015-04-024.01 Changes in Registrant's Certifying Accountantg7850.txt